← Evidence map

ArticleEMBO reports2026

Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2.

Binghong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41381736